These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36558958)

  • 1. MK2 Inhibitors as a Potential Crohn's Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity.
    Lebish EJ; Morgan NJ; Valentine JF; Beswick EJ
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.
    Aguirre JE; Beswick EJ; Grim C; Uribe G; Tafoya M; Chacon Palma G; Samedi V; McKee R; Villeger R; Fofanov Y; Cong Y; Yochum G; Koltun W; Powell D; Pinchuk IV
    Int Immunol; 2020 Jan; 32(1):57-68. PubMed ID: 31633754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?
    Opdenakker G; Vermeire S; Abu El-Asrar A
    Front Immunol; 2022; 13():983964. PubMed ID: 36164340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinases in Inflammatory Bowel Diseases.
    Marônek M; Marafini I; Gardlík R; Link R; Troncone E; Monteleone G
    J Inflamm Res; 2021; 14():1029-1041. PubMed ID: 33790618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
    Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
    Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.
    Mäkitalo L; Kolho KL; Karikoski R; Anthoni H; Saarialho-Kere U
    Scand J Gastroenterol; 2010 Aug; 45(7-8):862-71. PubMed ID: 20367198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
    Jakubowska K; Pryczynicz A; Iwanowicz P; Niewiński A; Maciorkowska E; Hapanowicz J; Jagodzińska D; Kemona A; Guzińska-Ustymowicz K
    Gastroenterol Res Pract; 2016; 2016():2456179. PubMed ID: 27034654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
    Elonen L; Wölfle L; de Laffolie J; Posovszky C;
    Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.
    Grim C; Noble R; Uribe G; Khanipov K; Johnson P; Koltun WA; Watts T; Fofanov Y; Yochum GS; Powell DW; Beswick EJ; Pinchuk IV
    J Crohns Colitis; 2021 Aug; 15(8):1362-1375. PubMed ID: 33506258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease.
    Tarris G; de Rougemont A; Estienney M; Charkaoui M; Mouillot T; Bonnotte B; Michiels C; Martin L; Belliot G
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK2 Is Required for Neutrophil-Derived ROS Production and Inflammatory Bowel Disease.
    Zhang T; Jiang J; Liu J; Xu L; Duan S; Sun L; Zhao W; Qian F
    Front Med (Lausanne); 2020; 7():207. PubMed ID: 32596245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical enteropathogenic
    Baumgartner M; Zirnbauer R; Schlager S; Mertens D; Gasche N; Sladek B; Herbold C; Bochkareva O; Emelianenko V; Vogelsang H; Lang M; Klotz A; Moik B; Makristathis A; Berry D; Dabsch S; Khare V; Gasche C
    Gut Microbes; 2022; 14(1):2143218. PubMed ID: 36415023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease.
    Feng YJ; Li YY
    J Dig Dis; 2011 Oct; 12(5):327-32. PubMed ID: 21955425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcerative colitis exacerbation after the onset of immune checkpoint inhibitor related colitis.
    Kayashima A; Shimozaki K; Hirata K; Mutaguchi M; Takabayashi K; Hayashi Y; Hosoe N; Ogata H; Sujino T; Kanai T
    Clin J Gastroenterol; 2021 Feb; 14(1):152-158. PubMed ID: 33058056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.